Association of a polymorphism in PON-1 gene with steroid-induced osteonecrosis of femoral head in Chinese Han population

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Wang, Zhiyao ^a   Zhang, Yanqiong ^b   Kong, Xiangying ^b   Li, Shangzhu ^c   Hu, Yimin ^c   Wang, Rongtian ^a   Li, Yan ^a   Lu, Chao ^a   Lin, Na ^b   Chen, Weiheng ^a  

^a WANGJING HOSPITAL   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Paraoxonase 1; Single nucleotide polymorphism; Steroid induced osteonecrosis of the femoral head

Indexed keywords

ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN; STEROID;

ADULT; ARTICLE; ASIAN; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; ETHNOLOGY; FEMALE; FEMUR HEAD NECROSIS; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARYLDIALKYLPHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; FEMUR HEAD NECROSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STEROIDS;

EID: 84887358750     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-186     Document Type: Article

References (26)

1. Atsumi T, Kuroki Y. Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res 1992, 277:22-30.
2. Assouline-Dayan Y, Chang C, Greenspan A, et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002, 32(2):94-124.
3. Petcu EB, Ivanovski S, Wright RG, et al. Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?. Diagn Pathol 2012, 7:78. doi: 10.1186/1746-1596-7-78, 10.1186/1746-1596-7-78, 3479027, 22770117.
4. Iwakiri K, Oda Y, Kaneshiro Y, et al. Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci 2008, 13(5):463-468. doi: 10.1007/s00776-008-1257-z, 10.1007/s00776-008-1257-z, 18843462.
5. Zhang Y, Wang S, Li D, et al. A systems biology-based classifier for hepatocellular carcinoma diagnosis. PLoS One 2011, 6(7):e22426. doi: 10.1371/journal.pone.0022426, 10.1371/journal.pone.0022426, 3145651, 21829460.
6. Fisher DE, Bickel WH. Corticosteroid-induced avascular necrosis: a clinical study of seventy-seven patients. J Bone Joint Surg Am 1971, 53(5):859-873.
7. Wang GJ, Dughman SS, Reger SI, et al. The effect of core decompression on femoral head blood flow in steroid-induced avascular necrosis of the femoral head. J Bone Joint Surg Am 1985, 67(1):121-124.
8. Jones JJ. Intravascular coagulation and osteonecrosis. Clin Orthop Relat Res 1992, 277:41-53.
9. Wang GJ, Sweet DE, Reger SI, et al. Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am 1977, 59(6):729-735.
10. Xiao-yan W, Xiao-hong N, Wei-heng C, et al. Effects of apolipoprotein A1 and B gene polymorphism on avascular necrosis of the femoral head in Chinese population. China journal of orthopaedics and traumatology 2008, 21(2):99-102. doi: 10.3969/j.issn.1003-0034.2008.02.006.
11. Primo-Parmo SL, Sorenson RC, Teiber J, et al. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996, 33(3):498-507. 10.1006/geno.1996.0225, 8661009.
12. Mackness B, Durrington PN, Mackness MI. The paraoxonase gene family and coronary heart disease. Curr Opin Lipidol 2002, 13(4):357-362. 10.1097/00041433-200208000-00002, 12151850.
13. Nassar BA, Darvesh S, Bevin LD, et al. Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease. Clin Biochem 2002, 35(3):205-209. 10.1016/S0009-9120(02)00296-5, 12074828.
14. Draganov DI, La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 2004, 369(1):78-88. doi:10.1007/s00210-003-0833-1, 10.1007/s00210-003-0833-1, 14579013.
15. Humbert R, Adler DA, Disteche CM, et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993, 3(1):73-76. doi: 10.1038/ng0193-73, 10.1038/ng0193-73, 8098250.
16. Obata T, Ito T, Yonemura A, et al. R192Q paraoxonase gene variant is associated with a change in HDL-cholesterol level during dietary caloric restriction in nondiabetic healthy males. J Atheroscler Thromb 2003, 10(1):57-62. 10.5551/jat.10.57, 12621166.
17. Voetsch B, Benke KS, Damasceno BP, et al. Paraoxonase 192 Gln Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 2002, 33(6):1459-1464. 10.1161/01.STR.0000016928.60995.BD, 12052975.
18. Hadjigeorgiou GM, Malizos K, Dardiotis E, et al. Paraoxonase 1 gene polymorphisms in patients with osteonecrosis of the femoral head with and without cerebral white matter lesions. J Orthop Res 2007, 25(8):1087-1093. doi: 10.1002/jor.20393, 10.1002/jor.20393, 17469180.
19. Oinuma K, Harada Y, Nawata Y, et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis 2001, 60(12):1145-1148. doi:10.1136/ard.60.12.1145, 10.1136/ard.60.12.1145, 1753447, 11709458.
20. Koo KH, Kim R, Kim YS, et al. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol 2002, 21(4):299-303. doi:10.1007/s100670200078, 10.1007/s100670200078, 12189457.
21. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Join t Surg(Am) 2006, 88(5):1117-1132. doi: 10.2106/JBJS.E.01041.
22. Lawlor DA, Day IN, Gaunt TR, et al. The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis. BMC Genet 2004, 5:17. doi: 10.1186/1471-2156-5-17, 449704, 15214960.
23. Wheeler JG, Keavney BD, Watkins H, et al. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 2004, 363(9410):689-695. doi: 10.1016/S0140-6736(04)15642-0, 10.1016/S0140-6736(04)15642-0, 15001326.
24. Likidlilid A, Akrawinthawong K, Poldee S, et al. Paraoxonase 1 polymorphisms as the risk factor of coronary heart disease in a Thai population. Acta Cardiol 2010, 65(6):681-691.
25. Liu H, Xia P, Liu M, et al. PON gene polymorphisms and ischaemic stroke: a systematic review and meta analysis. Int J Stroke 2013, 8(2):111-123. doi: 10.1111/j.1747-4949.2012.00813.x, 10.1111/j.1747-4949.2012.00813.x, 22631428.
26. Lazaros L, Markoula S, Kyritsis A, et al. Paraoxonase gene polymorphisms and stroke severity. Eur J Neurol 2010, 17(5):757-759. doi: 10.1111/j.1468-1331.2009.02860.x, 10.1111/j.1468-1331.2009.02860.x, 19930448.